Byhealth Co., Ltd (SHE:300146)
China · Delayed Price · Currency is CNY 10.50
-0.05 (-0.47%)
Apr 30, 2026, 3:07 PM CST
Byhealth Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 729.32 | 782.15 | 652.83 | 1,746 | 1,386 | 1,754 |
Depreciation & Amortization | 265.65 | 265.65 | 262.12 | 247.59 | 243.79 | 245.66 |
Other Amortization | 30.07 | 30.07 | 3.88 | 1.9 | 1.46 | 0.87 |
Loss (Gain) From Sale of Assets | -29.24 | -29.24 | -14.44 | -0.11 | 3.91 | -0.12 |
Asset Writedown & Restructuring Costs | 43.07 | 43.07 | 4.5 | 1.41 | 8.87 | 1.2 |
Loss (Gain) From Sale of Investments | -66.91 | -66.91 | -4.6 | -145.58 | -12.7 | -188.77 |
Provision & Write-off of Bad Debts | 6.52 | 6.52 | -1.97 | -2.27 | 1.62 | 5.46 |
Other Operating Activities | -198.67 | 58.41 | 49.14 | 52.1 | 41.37 | 42.48 |
Change in Accounts Receivable | -26.61 | -26.61 | 280.43 | -61.82 | -160.48 | -88.51 |
Change in Inventory | -90.63 | -90.63 | 338.28 | -102.54 | -78.95 | 22.56 |
Change in Accounts Payable | 271.68 | 271.68 | -965.17 | 362.63 | 41.1 | 39.25 |
Change in Other Net Operating Assets | -2.16 | -2.16 | 24.93 | 1.19 | -33.8 | -11.86 |
Operating Cash Flow | 903.8 | 1,214 | 685.94 | 2,051 | 1,379 | 1,819 |
Operating Cash Flow Growth | 0.57% | 76.94% | -66.56% | 48.77% | -24.19% | 16.13% |
Capital Expenditures | -129.41 | -133.38 | -305.75 | -1,257 | -244.78 | -263.16 |
Sale of Property, Plant & Equipment | 16.14 | 57.79 | 1.35 | 0.71 | 1.94 | 4.2 |
Cash Acquisitions | - | - | -925.56 | - | - | - |
Investment in Securities | -867.41 | -819.48 | -50.63 | -111 | -24.44 | -2,145 |
Other Investing Activities | 150.85 | 163.68 | 131.19 | 40.59 | 136 | 50.21 |
Investing Cash Flow | -829.82 | -731.38 | -1,149 | -1,327 | -131.28 | -2,354 |
Short-Term Debt Issued | - | - | - | - | 37.33 | - |
Long-Term Debt Issued | - | 1,841 | 1,537 | - | - | 9.69 |
Total Debt Issued | 1,991 | 1,841 | 1,537 | - | 37.33 | 9.69 |
Short-Term Debt Repaid | - | - | - | - | -37.33 | - |
Long-Term Debt Repaid | - | -2,365 | -18.8 | -35.62 | -32.74 | -288.54 |
Total Debt Repaid | -2,015 | -2,365 | -18.8 | -35.62 | -70.08 | -288.54 |
Net Debt Issued (Repaid) | -24.53 | -524.53 | 1,519 | -35.62 | -32.74 | -278.85 |
Issuance of Common Stock | - | - | 0.32 | 7.5 | 0.77 | 3,092 |
Repurchase of Common Stock | -105.2 | -105.2 | -241.7 | -18 | - | - |
Common Dividends Paid | -607.26 | -606.88 | -1,517 | -306.08 | -1,190 | -1,114 |
Other Financing Activities | 10.1 | - | -24 | -20 | -5 | -56.19 |
Financing Cash Flow | -726.88 | -1,237 | -263.3 | -372.2 | -1,227 | 1,643 |
Foreign Exchange Rate Adjustments | -7.8 | -3.42 | -5.06 | 13.03 | 37.9 | -34.04 |
Net Cash Flow | -660.71 | -757.7 | -731.81 | 365.2 | 58.26 | 1,074 |
Free Cash Flow | 774.39 | 1,080 | 380.19 | 794.08 | 1,134 | 1,556 |
Free Cash Flow Growth | 18.53% | 184.15% | -52.12% | -29.98% | -27.10% | 25.00% |
Free Cash Flow Margin | 12.21% | 17.24% | 5.56% | 8.44% | 14.43% | 20.94% |
Free Cash Flow Per Share | 0.47 | 0.65 | 0.22 | 0.47 | 0.66 | 0.93 |
Cash Income Tax Paid | 683.51 | 655.42 | 601.86 | 1,188 | 953.89 | 978.68 |
Levered Free Cash Flow | 832.98 | 860.48 | 72.88 | 290.48 | 760.39 | 958.5 |
Unlevered Free Cash Flow | 840.79 | 869.48 | 80.47 | 293.07 | 761.76 | 964.86 |
Change in Working Capital | 123.98 | 123.98 | -265.52 | 150.05 | -295.24 | -41.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.